Invention Grant
- Patent Title: Diagnostic agent and therapeutic agent for pancreatic cancer
- Patent Title (中): 胰腺癌的诊断剂和治疗剂
-
Application No.: US12297759Application Date: 2007-04-18
-
Publication No.: US08211630B2Publication Date: 2012-07-03
- Inventor: Hiroyuki Aburatani , Hiroko Iwanari , Isao Kohno
- Applicant: Hiroyuki Aburatani , Hiroko Iwanari , Isao Kohno
- Applicant Address: JP Tokyo JP Tokyo
- Assignee: Perseus Proteomics Inc.,The University of Tokyo
- Current Assignee: Perseus Proteomics Inc.,The University of Tokyo
- Current Assignee Address: JP Tokyo JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2006-114134 20060418; JP2006-291091 20061026; JP2006-347544 20061225
- International Application: PCT/JP2007/000423 WO 20070418
- International Announcement: WO2007/122820 WO 20071101
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; G01N33/53 ; G01N33/574
Abstract:
The present invention provides a novel diagnostic or therapeutic method for pancreatic cancer employing a blood marker. The present invention provides a diagnostic or therapeutic drug for pancreatic cancer containing an anti-AMIGO2 antibody.
Public/Granted literature
- US20100316568A1 DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR PANCREATIC CANCER Public/Granted day:2010-12-16
Information query
